Citadel Advisors
TNYA icon

Citadel Advisors’s Tenaya Therapeutics TNYA Stock Holding History

Citadel Advisors’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.91M Hold
4,200,000
– – ﹤0.01% 5328
2025
Q4 		$2.99M Buy
+4,200,000
New +$5.71M ﹤0.01% 5168
2025
Q3 		– Sell
-24,062
Closed -$24.2K – 14125
2025
Q2 		$14.7K Buy
+24,062
New +$12.2K ﹤0.01% 12162
2025
Q1 		– Sell
-438,886
Closed -$433K – 15575
2024
Q4 		$628K Sell
438,886
-1,896,265
-81% -$4.25M ﹤0.01% 8047
2024
Q3 		$4.51M Buy
2,335,151
+192,078
+9% +$542K ﹤0.01% 4092
2024
Q2 		$6.64M Sell
2,143,073
-104,443
-5% -$431K ﹤0.01% 3325
2024
Q1 		$11.8M Buy
2,247,516
+246,311
+12% +$1.18M ﹤0.01% 2728
2023
Q4 		$6.48M Sell
2,001,205
-104,672
-5% -$226K ﹤0.01% 3437
2023
Q3 		$5.37M Buy
2,105,877
+1,090,819
+107% +$4.57M ﹤0.01% 3541
2023
Q2 		$5.96M Sell
1,015,058
-84,022
-8% -$488K ﹤0.01% 3378
2023
Q1 		$3.13M Sell
1,099,080
-32,991
-3% -$92.7K ﹤0.01% 4562
2022
Q4 		$2.28M Buy
1,132,071
+914,733
+421% +$2.23M ﹤0.01% 5234
2022
Q3 		$631K Buy
217,338
+168,378
+344% +$786K ﹤0.01% 7950
2022
Q2 		$276K Buy
+48,960
New +$396K ﹤0.01% 9978

Other funds holding TNYA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.02B AUM 85.32% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Citadel Advisors's TNYA Position: Q1 2026 in Review

Citadel Advisors held its Tenaya Therapeutics (TNYA) position steady in Q1 2026 at 4,200,000 shares worth $2.91M. The position accounts for ﹤0.01% of the portfolio, ranked #5328.

Citadel Advisors first reported a position in TNYA in Q2 2022 and has held it in 14 quarters since. The position peaked at $11.8M in Q1 2024. 103 funds tracked by Wall St. Rank hold TNYA as of Q1 2026.

  • Citadel Advisors held 4,200,000 shares of Tenaya Therapeutics worth $2.91M as of Q1 2026.
  • Citadel Advisors left its Tenaya Therapeutics share count unchanged in Q1 2026.
  • Tenaya Therapeutics made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #5328 holding.
  • Citadel Advisors first reported a position in Tenaya Therapeutics in Q2 2022 and has held it in 14 quarters since.
  • Citadel Advisors's Tenaya Therapeutics position peaked at $11.8M in Q1 2024.
  • 103 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.